We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

89 hedge funds and large institutions have $148M invested in Chimerix, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less funds holding

Funds holding: 10289 (-13)

14% less capital invested

Capital invested by funds: $171M → $148M (-$23.5M)

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

95% less call options, than puts

Call options by funds: $3K | Put options by funds: $65K

Holders
89
Holders Change
-13
Holders Change %
-12.75%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
38
Reduced
21
Closed
21
Calls
$3K
Puts
$65K
Net Calls
-$62K
Net Calls Change
+$6K
Name Holding Trade Value Shares
Change
Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$15.5M +$410K +96,263 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.1M -$4.49M -1,053,849 -21%
BlackRock
3
BlackRock
New York
$14.4M +$917K +215,268 +6%
RG
4
Redmile Group
California
$14M +$6.64K +1,560 +0%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$9.95M +$319K +74,910 +3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.23M +$540K +126,847 +6%
Morgan Stanley
7
Morgan Stanley
New York
$7.94M +$1.94M +456,290 +29%
AC
8
Armistice Capital
New York
$5.06M +$179K +42,000 +3%
OM
9
Opaleye Management
Massachusetts
$4.61M +$149K +35,000 +3%
AG
10
Artal Group
Luxembourg
$3.89M +$2.13M +500,000 +100%
NLVP
11
New Leaf Venture Partners
New York
$3.89M +$4.26M +1,000,000 New
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$3.89M +$4.26M +1,000,000 New
State Street
13
State Street
Massachusetts
$3.57M +$47.1K +11,070 +1%
Man Group
14
Man Group
United Kingdom
$3.56M -$90.3K -21,209 -2%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$2.16M +$204K +47,799 +9%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.06M +$580K +136,296 +35%
Northern Trust
17
Northern Trust
Illinois
$1.94M +$24.6K +5,767 +1%
AC
18
Aisling Capital
New York
$1.84M
Renaissance Technologies
19
Renaissance Technologies
New York
$1.51M +$215K +50,408 +15%
RPAM
20
Rhenman & Partners Asset Management
Sweden
$1.33M -$2.98K -700 -0.2%
Axa
21
Axa
France
$1.24M
Connor, Clark & Lunn Investment Management (CC&L)
22
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.14M +$65.8K +15,453 +6%
Victory Capital Management
23
Victory Capital Management
Texas
$1.08M -$64.5K -15,140 -5%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$1.04M +$83.8K +19,685 +8%
Millennium Management
25
Millennium Management
New York
$1.01M -$106K -24,988 -9%

CMRX Hedge Fund Activity: Q3 2018 in Review

89 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q3 2018, worth a combined $148M — down 14% from $171M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CMRX and 8 opened new positions — a net loss of 13 holders — while 21 trimmed existing stakes and 38 added.

The largest buyer was New Leaf Venture Partners, opening a new position worth an estimated $4.26M. The largest seller was Fidelity Investments, cutting an estimated $4.49M.

  • 89 institutional investors held Chimerix, Inc. (CMRX) as of Q3 2018, down from 102 in Q2 2018.
  • Funds reported $148M of Chimerix, Inc. stock for Q3 2018, down 14% quarter-over-quarter.
  • 8 funds opened new Chimerix, Inc. positions in Q3 2018 and 21 closed out, a net change of -13 holders.
  • The largest Chimerix, Inc. buyer in Q3 2018 was New Leaf Venture Partners, an estimated $4.26M added.
  • The largest Chimerix, Inc. seller in Q3 2018 was Fidelity Investments, an estimated $4.49M sold.

Based on aggregated 13F filings for Q3 2018.